Dapagliflozin vs Risankizumab

Dapagliflozin vs Risankizumab: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Risankizumab.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6.

Molecular Weight: Dapagliflozin — 408.8730 g/mol.

Type: Dapagliflozin — Small molecule; Risankizumab — Antibody.